Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.860
-0.140 (-4.66%)
At close: Jul 26, 2024, 2:58 PM
2.910
+0.050 (1.75%)
After-hours: Jul 26, 2024, 6:30 PM EDT

Armata Pharmaceuticals Revenue

Armata Pharmaceuticals had revenue of $966.00K in the quarter ending March 31, 2024, with 21.36% growth. This brings the company's revenue in the last twelve months to $4.70M, down -7.28% year-over-year. In the year 2023, Armata Pharmaceuticals had annual revenue of $4.53M, down -17.77%.

Revenue (ttm)
$4.70M
Revenue Growth
-7.28%
P/S Ratio
22.39
Revenue / Employee
$71,197
Employees
66
Market Cap
105.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.53M-979.00K-17.77%
Dec 31, 20225.51M1.03M23.11%
Dec 31, 20214.47M3.65M443.62%
Dec 31, 2020823.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Journey Medical 80.00M
Augmedix 48.70M
BrainsWay 34.26M
Omega Therapeutics 4.94M
I-Mab 3.90M
VistaGen Therapeutics 1.06M
Oramed Pharmaceuticals 674.00K
Cardiff Oncology 610.00K
Revenue Rankings